Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia
- 30 November 1996
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 90 (10) , 587-592
- https://doi.org/10.1016/s0954-6111(96)90016-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A Three-year Study of Severe Community-acquired Pneumonia With Emphasis on OutcomeChest, 1993
- Evaluation of New Anti-Infective Drugs for the Treatment of Respiratory Tract InfectionsClinical Infectious Diseases, 1992
- Granulocyte Colony-Stimulating Factor Enhances Pulmonary Host Defenses in Normal and Ethanol-Treated RatsThe Journal of Infectious Diseases, 1991
- Predicting Death in Patients Hospitalized for Community-acquired PneumoniaAnnals of Internal Medicine, 1991
- Protective Effect of Recombinant Human Granulocyte Colony-Stimulating Factor Against Pneumococcal Infections in Splenectomized MiceArchives of Surgery, 1990
- Leads from the MMWR. Revision of the CDC surveillance case definition for acquired immunodeficiency syndromePublished by American Medical Association (AMA) ,1987
- APACHE IICritical Care Medicine, 1985
- Treatment of community-acquired pneumoniasThe American Journal of Medicine, 1985